Komori
Fukoku (5185) · FactAdvanced

Continuation of Research and Development Activities

First written in FY2017-Q1. 24 of 34 entries say "Restated". Latest entry: FY2026.

34entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q1 – FY2020-Q32016: 220162017: 420172018: 420182019: 420192020: 420202021: 320212022: 320222023: 420232024: 320242025: 220252026: 12026
Same theme, other companies
Continuation of Company-wide R&D Activities and Resource InvestmentA theme 204 companies write about · 0 as a headwind · 217 as a tailwind

56 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 219 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「For its thermal-management product, the heat-dissipation gap filler, the company has entered national phases in multiple foreign countries, including the United States and China, for applications filed internationally and is proceeding toward obtaining patent rights. It has also completed 2 more suitable international patent applications and obtained patent rights in Japan for both through accelerated examination.」

    R&D expenses increased from ¥2,272 million to ¥2,383 million. The company advanced foreign national-phase filings and patent acquisition for its heat-dissipation gap filler, obtained 2 Japanese patents, and completed patent applications for soft grippers and silicone materials.
  2. FY2026-H1RestatedAnnual report

    「Total R&D expenses for the six-month consolidated accounting period were ¥1,196 million. There were no significant changes in the status of the Group's R&D activities during the six-month consolidated accounting period.」

    The company recorded R&D expenses of ¥1,196 million and stated that there had been no significant changes in its R&D activities.
  3. FY2025AdvancedAnnual report

    「Total R&D expenses for the fiscal year increased from ¥1,896 million in the previous consolidated fiscal year to ¥2,272 million.」

    R&D expenses increased from ¥1,896 million to ¥2,272 million, while the company advanced development and patent applications for electric vehicles, space, agricultural machinery and soft robotics, among other areas.
  4. FY2025-H1RestatedAnnual report

    「Total R&D expenses for the six-month consolidated accounting period were ¥1,132 million. There were no significant changes in the status of the Group's R&D activities during the six-month consolidated accounting period.」

    The company stated that there had been no significant changes in its R&D activities and disclosed R&D expenses of ¥1,132 million for the six-month consolidated accounting period.
  5. FY2024AdvancedAnnual report

    「In particular, for wiper blade rubber, its core product, the introduction of a large environmental testing chamber capable of testing vehicles enabled the company to conduct in-house some of the performance evaluations previously performed by Tier 1 manufacturers, significantly shortening the development period.」

    The company explained that it shortened the development period by conducting in-house performance evaluations of wiper blade rubber after introducing a large environmental testing chamber. R&D expenses were ¥1,896 million.
  6. FY2024-Q3RestatedAnnual report

    「Total R&D expenses for the nine months ended the third quarter were ¥1,417 million. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter.」

    The company disclosed R&D expenses of ¥1,417 million for the nine months ended Q3, while stating that there had been no significant changes in its R&D activities.
  7. FY2024-Q2RestatedAnnual report

    「Total R&D expenses for the six months ended the second quarter were ¥925 million. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter.」

    R&D expenses of ¥925 million were recorded, and the Company states that there were no material changes in the status of its R&D activities.
  8. FY2024-Q1RestatedAnnual report

    「Total R&D expenses for the six months ended the first quarter were ¥470 million. There were no material changes in the status of the Group's R&D activities during the six months ended the first quarter.」

    R&D expenses of ¥470 million were recorded, with no material changes reported in the status of R&D activities.
  9. FY2023AdvancedAnnual report

    「As many of the raw materials used in rubber are petroleum-based, the Company is shifting to biomass-based raw materials and those that generate less CO2, while developing materials with improved processability that enable lower-energy manufacturing. Total R&D expenses for the fiscal year were ¥1,653 million.」

    R&D expenses totaled ¥1,653 million, up from ¥1,592 million in the previous year. Development activities are described in detail for CASE and EV-related components, materials with a lower environmental burden, aerospace, semiconductors and Life Sciences.
  10. FY2023-Q3RestatedAnnual report

    「Total R&D expenses for the nine months ended the third quarter were ¥1,219 million. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter.」

    The Company states that there were no material changes in its R&D activities and reports R&D expenses of ¥1,219 million for the nine months ended the third quarter.
  11. FY2023-Q1RestatedAnnual report

    「Total R&D expenses for the six months ended the first quarter were ¥391 million. There were no material changes in the status of the Group's R&D activities during the six months ended the first quarter.」

    R&D expenses of ¥391 million were recorded, and the Company states that there were no material changes in its R&D activities.
  12. FY2022AdvancedAnnual report

    「As many of the raw materials used in rubber are petroleum-based, the Company is shifting to biomass-based raw materials and those that generate less CO2, while developing materials with improved processability that enable lower-energy manufacturing. Total R&D expenses for the fiscal year were ¥1,592 million.」

    R&D expenses increased from ¥1,390 million to ¥1,592 million, with development targets specified in areas including CASE products, EV-related components, materials with a lower environmental burden and Life Sciences products.
  13. FY2022-Q3RestatedAnnual report

    「Total R&D expenses for the nine months ended the third quarter were ¥1,204 million. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter.」

    The Company states that there were no material changes in its R&D activities and reports R&D expenses of ¥1,204 million for the nine months ended the third quarter.
  14. FY2022-Q2RestatedAnnual report

    「Total R&D expenses for the six months ended the second quarter were ¥800 million. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter.」

    The Company states that there were no material changes in its R&D activities and reports R&D expenses of ¥800 million for the six months ended the second quarter.
  15. FY2021AdvancedAnnual report

    「The Company also actively pursued research into new materials and technologies and development of their applications, as well as materials and processes that reduce the environmental burden from chlorine, solvents, CO2 and other substances. Total R&D expenses for the fiscal year were ¥1,390 million.」

    The Company describes the integration of its organizations into the Technology Development Headquarters, the development of CASE, medical and new-material applications, and R&D expenses of ¥1,390 million for the fiscal year.
  16. FY2021-Q3RestatedAnnual report

    「Total R&D expenses for the nine months ended the third quarter were ¥1,049 million. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter.」

    R&D expenses of ¥1,049 million were recorded, and the Company states that there were no material changes in the status of its R&D activities.
  17. FY2021-Q2RestatedAnnual report

    「Total R&D expenses for the six months ended the second quarter were ¥705 million. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter.」

    R&D expenses of ¥705 million were recorded, and the Company states that there were no material changes in the status of its R&D activities.
  18. FY2021-Q1RestatedAnnual report

    「Total R&D expenses for the six months ended the first quarter were ¥391 million. There were no material changes in the status of the Group's R&D activities during the six months ended the first quarter.」

    R&D expenses of ¥391 million were recorded, and the Company states that there were no material changes in its R&D activities.
  19. FY2020AdvancedAnnual report

    「The Company newly began mass production of gaskets for fuel-cell vehicle cooling systems for a domestic component manufacturer.」

    New orders and the start of mass production are described for fuel-cell vehicle gaskets, resin boots, vibration-control rubber for railways, mounts for construction machinery, and products manufactured at overseas sites.
  20. FY2020-Q3RestatedAnnual report

    「Total R&D expenses for the nine months ended the third quarter were ¥1,322 million. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter.」

    R&D expenses of ¥1,322 million were recorded, and the Company states that there were no material changes in its R&D activities.
  21. FY2020-Q2RestatedAnnual report

    「Total R&D expenses for the six months ended the second quarter were ¥893 million. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter.」

    R&D expenses of ¥893 million were recorded, and the Company states that there were no material changes in its R&D activities.
  22. FY2020-Q1RestatedAnnual report

    「Total R&D expenses for the six months ended the first quarter were ¥456 million. There were no material changes in the status of the Group's R&D activities during the six months ended the first quarter.」

    R&D expenses of ¥456 million were recorded, and the Company states that there were no material changes in its R&D activities.
  23. FY2019RestatedAnnual report

    「During the fiscal year, R&D activities focused on product development in growth industries, including priority automotive products as well as industrial machinery and OA equipment. The Company also actively pursued research into new materials and technologies and development of their applications. Total R&D expenses for the fiscal year were ¥1,709 million.」

    R&D in growth fields such as automotive, industrial machinery and OA, as well as research into new materials and technologies, continued. R&D expenses totaled ¥1,709 million.
  24. FY2019-Q3RestatedAnnual report

    「Total R&D expenses for the nine months ended the third quarter were ¥1,306 million. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter.」

    R&D expenses of ¥1,306 million were recorded, and the Company states that there were no material changes in its R&D activities.
  25. FY2019-Q2RestatedAnnual report

    「Total R&D expenses for the six months ended the second quarter were ¥883 million. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter.」

    R&D expenses of ¥883 million were recorded, and the Company states that there were no material changes in its R&D activities.
  26. FY2019-Q1RestatedAnnual report

    「Total R&D expenses for the six months ended the first quarter were ¥457 million. There were no material changes in the status of the Group's R&D activities during the six months ended the first quarter.」

    R&D expenses of ¥457 million were recorded, and the Company states that there were no material changes in its R&D activities.
  27. FY2018AdvancedAnnual report

    「During the fiscal year, R&D activities focused on product development in growth industries, including priority automotive products as well as industrial machinery and OA equipment. The Company also actively pursued research into new materials and technologies and development of their applications. Total R&D expenses for the fiscal year were ¥1,784 million.」

    R&D expenses totaled ¥1,784 million, with numerous development results, including new orders and the start of mass production in automotive, industrial machinery and OA applications, described in detail.
  28. FY2018-Q3RestatedAnnual report

    「Total R&D expenses for the nine months ended the third quarter were ¥1,336 million. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter.」

    R&D expenses of ¥1,336 million were recorded, and the Company states that there were no material changes in its R&D activities.
  29. FY2018-Q2RestatedAnnual report

    「Total R&D expenses for the six months ended the second quarter were ¥884 million. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter.」

    R&D expenses of ¥884 million were recorded, and the Company states that there were no material changes in its R&D activities.
  30. FY2018-Q1RestatedAnnual report

    「Total R&D expenses for the six months ended the first quarter were ¥421 million. There were no material changes in the status of the Group's R&D activities during the six months ended the first quarter.」

    R&D expenses of ¥421 million were recorded, and the Company states that there were no material changes in its R&D activities.
  31. FY2017AdvancedAnnual report

    「During the fiscal year, R&D activities focused on product development in growth industries, including priority automotive products as well as industrial machinery and OA equipment. The Company also actively pursued research into new materials and technologies and development of their applications. Total R&D expenses for the fiscal year were ¥1,727 million.」

    R&D expenses of ¥1,727 million were recorded, with development activities including new orders and the start of mass production in automotive, industrial machinery and OA applications described in detail.
  32. FY2017-Q3RestatedAnnual report

    「Total R&D expenses for the nine months ended the third quarter were ¥1,302 million. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter.」

    R&D expenses for the nine months ended the third quarter were ¥1,302 million, and the Company states that there were no material changes in its R&D activities.
  33. FY2017-Q2RestatedAnnual report

    「Total R&D expenses for the six months ended the second quarter were ¥881 million. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter.」

    R&D expenses for the first half were ¥881 million, and the Company states that there were no material changes in its R&D activities.
  34. FY2017-Q1First statedAnnual report

    「Total R&D expenses for the six months ended the first quarter were ¥450 million. There were no material changes in the status of the Group's R&D activities during the six months ended the first quarter.」

    R&D expenses of ¥450 million were recorded, and the Company states that there were no material changes in its R&D activities.
Moved together

"Development of New Technologies and Products and Cost Reduction" moved the same way as this thread, in the same document, in 9 of its 34 moves.

987655★123456
  1. ★This thread
  2. 1Development of New Technologies and Products and Cost Reduction9×
  3. 2Strengthening Corporate Governance8×
  4. 3Expanding locations into Eastern Europe and Central America from an Asia-ASEAN base7×
  5. 4Exploring New Businesses and Developing Products in Growth Industries6×
  6. 5Burden from upfront investment and rising costs5×
  7. 6Life Sciences-Related Business and Commercialization of Microfluidic Chips5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Fukoku's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.